Covid-Related Tumors Induced by Pfizer and Moderna Vaccines May Be Countered with Ivermectin
=============================================================================
In the world of medical research, the anti-parasitic drug Ivermectin has been making waves due to its potential anticancer properties. While the drug is primarily known for its effectiveness against parasitic infections, recent studies suggest that it may have a role to play in cancer treatment as well.
However, it's important to clarify some misconceptions that have been circulating. There is no credible scientific evidence to support the claim that Pfizer and Moderna COVID-19 mRNA vaccines cause "chemotherapy-resistant turbo cancers," nor is there validated proof that Ivermectin can specifically combat such alleged vaccine-induced cancers.
In laboratory and some real-world observational contexts, Ivermectin has demonstrated anticancer potential. The drug appears to affect cancer cells by disrupting key signaling pathways essential for cancer growth and spread, enhancing oxidative stress selectively in cancer cells, impairing tumor blood vessel growth, and potentially reversing drug resistance.
Recent peer-reviewed studies and reviews highlight the potential of Ivermectin in preclinical and some clinical settings. For instance, in a breast cancer mouse model, Ivermectin was found to induce cell cycle arrest, preferentially inhibit cancer stem-like cells, and inhibit tumor growth.
However, it's crucial to note that these findings remain preliminary. The existing studies emphasize the need for well-designed, large-scale clinical trials to properly assess Ivermectin’s effectiveness and safety as an oncologic therapy.
Meanwhile, claims about "turbo cancers" caused by these vaccines and successfully treated by Ivermectin derive mainly from controversial or speculative sources without broad expert endorsement.
The potential of Ivermectin in cancer treatment has been the subject of a lawsuit filed by doctors Paul Marik, Mary Talley Bowden, and Robert Apter in a federal court in Texas. The lawsuit, which was later overruled by the U.S. Court of Appeals for the Fifth Circuit, accused the FDA of meddling with their capacity to practice medicine.
The FDA, in response, has taken down posts urging people to avoid the usage of Ivermectin for COVID-19, including one that read: "You are not a horse. You are not a cow. Seriously, y'all. Stop it." The agency maintains that Ivermectin is not approved for the prevention or treatment of COVID-19.
As the research on Ivermectin and cancer progresses, it's essential to approach the findings with a critical eye and await the results of well-designed, large-scale clinical trials before making any definitive conclusions. The current state of knowledge, as of mid-2025, is that Ivermectin has demonstrated anticancer potential in laboratory and some real-world observational contexts, but further rigorous, peer-reviewed clinical research is needed before it can be recommended for cancer treatment.
References: 1. [Source 1] 2. [Source 2] 3. [Source 3]
